Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC

K-Number: K924769 · 1993-02-23

ApplicantThe Binding Site, Ltd.
Decision Date1993-02-23
Product CodeCFF
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC is the device name listed in this FDA 510(k) record. The listed applicant is The Binding Site, Ltd.. It received FDA 510(k) clearance on 1993-02-23 under 510(k) number K924769. The device is classified under product code CFF. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC?

IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC is a medical device that received FDA 510(k) clearance on 1993-02-23. The listed applicant is The Binding Site, Ltd.. The 510(k) number is K924769.

When did IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC receive FDA 510(k) clearance?

IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC received FDA 510(k) clearance on 1993-02-23, under 510(k) number K924769.

Who is the listed applicant for IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC?

The FDA 510(k) record lists The Binding Site, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC?

The FDA product code for IMMUNOGLOBULINS G, A & M AND LIGHT CHAIN SPECIFIC is CFF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing The Binding Site, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K231290Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitK090920HUMAN IGG SUBCLASS LIQUID REAGENT KITS (FOR USE ON HITACHI 911/ 912/ 917 AND MODULAR P)K083289HUMAN BETA-2 MICROGLOBULIN KITK082129HUMAN IGM LIQUID REAGENT KIT FOR USE ON THE SPAPLUS ANALYZERK081827HUMAN IGA LIQUID REAGENT KIT FOR USE ON SPAPLUSK081674BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HUMAN ANTI-GLIADIN (MGP) IGA EIA KIT; (IGA OR IGG)

View all 115 devices →

Related Devices (Code: CFF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K203184HYDRASHIFT 2/4 isatuximabSebiaK192095CAPI 3 Immunotyping, Capillarys 3 TeraSebiaK190851HYDRASHIFT 2/4 daratumumabSebiaK172195HYDRASHIFT 2/4 daratumumab, daratumumab ControlSebiaK161928CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROLSebiaK120169INTERLAB IFE TEST USING G 26 VER. 2.0 INSTRUMENTGrifols USA, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑